Health status considerations: Generally healthy adults with physician clearance, individuals without contraindications (pregnancy, active malignancy, severe organ disease), those willing to commit to proper administration protocols and monitoring, and patients who understand the research-purposes-only status and informed consent requirements
Allergic reactions are possible
Mechanism: Promotes angiogenesis, fibroblast migration, and collagen synthesis
Color change from clear or pale blue to yellow, brown, or green indicates copper oxidation and peptide bond cleavage
Both are preclinical, but they line up with the regenerative story rather than the pain-suppression one
no proven morning-versus-night advantage Injectable use No FDA-approved product label or validated self-injection schedule Sources: Topical GHK-Cu phase 2 study Direct answer: There is no clinically proven universal best time for GHK-Cu